Summary

The medical polymer market is projected to reach USD 71.92 billion by 2031 from USD 48.27 billion in 2026, at a CAGR of 8.3% during the forecast period. The medical polymer market is experiencing rapid growth due to progress in healthcare, materials engineering, and patient-focused innovation. The increased prevalence of chronic diseases, aging population, and the need for minimally invasive procedures is creating a preference for advanced polymers that provide flexibility, security, and accuracy. The considerable shift in the use of disposable medical products for sanitation and fewer contaminants has contributed to the proliferation of components made from polymers. The science of polymers is advancing to create polymers and materials with superior mechanical strength, durability, antimicrobial properties, and compatibility with active sterilization techniques. Advances in knowledge and developments have resulted in breakthroughs in polymers that can hold shapes or be bioresorbable, offering opportunities in the areas of drug delivery devices and tissue engineering. The proliferation of medical-grade 3D printing has revolutionized this area because custom-designed implants and devices can now be developed rapidly. There is increased attention on sustainable practices, leading to interest in recyclable and biodegradable polymers. The medical elastomers segment is estimated to account for the second-largest share of the medical polymer market during the forecast period. Medical elastomers account for the second-largest share of the medical polymer market due to their flexibility, durability, and biocompatibility, allowing them to be used for hundreds of precise applications in critical healthcare. Many of the devoted elastomer applications are products used to contain a fluid or products that need to be manipulated with constant movement, stretching or compression, like seals, gaskets, tubing, syringes, plungers, and catheter components. Medical elastomer products are best known because of their chemical resistance, resistance to temperature swings, and resistance to sterilization techniques, which enables reliable products in high-stress medical applications. Because silicone elastomers, thermoplastic elastomers (TPE), and rubber materials are often specifically mentioned in the literature due to increased comfort above conventional or hard polymers, they are favored for wearable medical devices and skin-contact applications. In addition, the influence of minimization continues to drive performance in elastomeric materials, as do the advanced design aspects influencing drug delivery systems, automated enclosed testing systems, and lifestyle diagnostic devices. Furthermore, elastomeric materials are especially amenable to automated manufacturing and/or molding with E-modulus and tensile strength decreases, enabling cost-effective product production at considerably large amounts. Medical disposables accounted for the second-largest application in the medical polymer market during the forecast period. Medical disposables are the second-largest application in the medical polymer market. Items such as syringes, gloves, IV bags, tubing and connections, surgical drapes, and masks are designed for single-use to prevent cross-contamination and to maintain a sterile environment. The emphasis on infection prevention and the regulations supporting infection control have increased demand for disposable medical items. Due to their excellent processability, low cost, and compatibility with sterilizing processes, the polymers used in medical disposables are primarily polypropylene, polyethylene, and PVC. The increase in hospital stays, enhanced surgical procedures, and outpatient care, especially in developing areas, is driving demand for good quality disposables. The convenience of ready-to-use pre-sterilized items can add efficiency in busy medical settings. As health care continues to focus on safety, cost-effective practices and efficiencies, polymer medical disposables will be an important future growth area. Injection molding is the second-largest manufacturing technology in the medical polymer market during the forecast period. Injection molding is the second-largest manufacturing technology in the medical polymer space because it can produce highly precise and complex components at scale with good reliability and efficiency. Injection molding is used to produce a wide variety of medical products, such as housing for diagnostic equipment, surgical instrument handles, syringes, connectors, and components of implantable devices. Injection molding is compatible with many medical-grade polymers, such as polycarbonate, polypropylene, and ABS. Injection molding can be made to tight tolerances with complex geometries, all of which are relevant in meeting the safety and performance requirements of the medical device industry. Injection molding is also compatible with automation and is conducive to produce item at large volumes while being cost-effective with high-quality output. Recent advancements in multi-shot and micro fabrications further enhance application range as well. North America market is projected to be the second-fastest growing region in the medical polymer market during the forecast period. North America is the second-fastest growing region in the medical polymer market. Per capita healthcare expenses are rising, driven by expanding insurance coverage in the US and strong public and private healthcare investments in Canada. The medical devices, packaging, and wound care categories are projected to account for greater growth in North America than any other world region as healthcare advances. The US has one of the most innovative healthcare environments in the world. The country has a developed healthcare infrastructure, a strong research and development (R&D) ecosystem, and a strong partnership with the polymer industry. Extensive primary interviews were conducted to determine and verify the market size for several segments and sub-segments, and information was gathered through secondary research. The breakdown of primary interviews is given below: ・By Company Type: Tier 1: 40%, Tier 2: 30%, and Tier 3: 30% ・By Designation: Directors: 30%, Managers: 20%, and Others: 50% ・By Region: Asia Pacific: 40%, Europe: 10%, North America: 20%, Middle East & Africa: 20%, and South America: 10% BASF SE (Germany), SABIC (Saudi Arabia), Covestro AG (Germany), Celanese Corporation (US), Evonik Industries (Germany), Arkema (France), Solvay (Belgium), Kuraray Co., Ltd. (Japan), Momentive Performance Materials Inc. (US), and DuPont (US) are some of the key players in the medical polymer market. The study includes an in-depth competitive analysis of these key players in the medical polymer market, with their company profiles, recent developments, and key market strategies. Research Coverage The market study covers the medical polymer market across various segments. It aims to estimate the market size and the growth potential of this market across different segments based on type, application, manufacturing technology, and region. The study also includes an in-depth competitive analysis of key players in the market, their company profiles, key observations related to their products and business offerings, recent developments undertaken by them, and key growth strategies adopted by them to improve their position in the medical polymer market. Key Benefits of Buying the Report The report is expected to help the market leaders/new entrants in this market share the closest approximations of the revenue numbers of the overall medical polymer market and its segments and sub-segments. This report is projected to help stakeholders understand the competitive landscape of the market, gain insights to improve the position of their businesses, and plan suitable go-to-market strategies. The report also aims to help stakeholders understand the pulse of the market and provides them with information on the key market drivers, restraints, challenges, and opportunities. The report provides insights on the following pointers: ・ Analysis of key drivers (Increasing demand for biocompatible materials, Growing aging population globally, Advancements in medical technology, Regulatory support for medical-grade materials), restraints (Regulatory complexities and approvals, High competition from alternative materials, Environmental sustainability concerns), opportunities (Growth in regenerative medicine, Demand for minimally invasive devices, Advancements in biodegradable polymers), challenges (Cost constraints for novel materials, Long-term durability and degradation control). ・ Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the medical polymer market ・ Market Development: Comprehensive information about lucrative markets – the report analyses the medical polymer market across varied regions ・ Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the medical polymer market ・ Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like BASF SE (Germany), SABIC (Saudi Arabia), Covestro AG (Germany), Celanese Corporation (US), Evonik Industries (Germany), Arkema (France), Solvay (Belgium), Kuraray Co., Ltd. (Japan), Momentive Performance Materials Inc. (US), and DuPont (US), among others

ページTOPに戻る

Table of Contents

1 INTRODUCTION 28
1.1 STUDY OBJECTIVES 28
1.2 MARKET DEFINITION 28
1.3 INCLUSIONS AND EXCLUSIONS 29
1.4 STUDY SCOPE 30
1.4.1 YEARS CONSIDERED 31
1.5 CURRENCY CONSIDERED 31
1.6 UNITS CONSIDERED 31
1.7 STAKEHOLDERS 31
2 EXECUTIVE SUMMARY 32
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 32
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS 34
2.3 DISRUPTIVE TRENDS SHAPING THE MARKET 36
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 37
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 38
3 PREMIUM INSIGHTS 39
3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN MEDICAL POLYMER MARKET 39
3.2 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE AND COUNTRY 40
3.3 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY 41
3.4 MEDICAL POLYMER MARKET, BY APPLICATION 41
3.5 MEDICAL POLYMER MARKET, BY COUNTRY 42
4 MARKET OVERVIEW 43
4.1 INTRODUCTION 43
4.2 MARKET DYNAMICS 43
4.2.1 DRIVERS 44
4.2.1.1 Increasing demand for biocompatible and high-performance materials 44
4.2.1.2 Growing aging population and healthcare expenditure 44
4.2.1.3 Advancements in medical devices and minimally invasive procedures 44
4.2.1.4 Rise in chronic diseases 45
4.2.1.5 Increasing adoption of stringent medical-grade material and biocompatibility requirements 45
4.2.2 RESTRAINTS 46
4.2.2.1 Stringent regulatory and material qualification requirements 46
4.2.2.2 High competition from alternative polymers and materials 46
4.2.2.3 Environmental sustainability and chemical regulatory concerns 46
4.2.3 OPPORTUNITIES 47
4.2.3.1 Growth in regenerative medicine and tissue engineering 47
4.2.3.2 Advancements in biodegradable and bioresorbable polymers 47
4.2.3.3 Growing adoption of 3D-printed and patient-specific medical devices 47
4.2.3.4 Increasing demand for minimally invasive and patient-specific devices 48
4.2.4 CHALLENGES 48
4.2.4.1 High cost and lengthy qualification of novel medical-grade materials 48
4.2.4.2 Balancing sustainability with durability, sterilization, and biocompatibility 48
4.2.4.3 Evolving restrictions on PFAS and other chemicals used in medical polymer applications 49
4.3 UNMET NEEDS IN MEDICAL POLYMER MARKET 49
4.3.1 WHITE SPACE OPPORTUNITIES 50
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 52
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 53
4.5.1 KEY MOVES AND STRATEGIC FOCUS 53
5 INDUSTRY TRENDS 55
5.1 PORTER’S FIVE FORCES ANALYSIS 55
5.1.1 THREAT FROM NEW ENTRANTS 56
5.1.2 THREAT OF SUBSTITUTES 56
5.1.3 BARGAINING POWER OF BUYERS 56
5.1.4 BARGAINING POWER OF SUPPLIERS 57
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 57
5.2 MACROECONOMIC INDICATORS 58
5.2.1 GLOBAL GDP TRENDS 58
5.2.2 HEALTHCARE INDUSTRY TRENDS 60
5.3 VALUE CHAIN ANALYSIS 61
5.3.1 RAW MATERIAL SUPPLIERS 62
5.3.2 MANUFACTURERS 62
5.3.3 DISTRIBUTION 62
5.3.4 END USERS 62
5.4 ECOSYSTEM 63
5.5 PRICING ANALYSIS 64
5.5.1 AVERAGE SELLING PRICE TREND, BY REGION 64
5.5.2 AVERAGE SELLING PRICE TREND, BY APPLICATION 65
5.6 TRADE ANALYSIS 66
5.6.1 IMPORT SCENARIO 66
5.6.2 EXPORT SCENARIO 67
5.7 KEY CONFERENCES & EVENTS 67
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 68
5.8.1 REVENUE SHIFT AND NEW REVENUE POCKETS FOR MEDICAL POLYMER MANUFACTURERS 68
5.9 INVESTMENT AND FUNDING SCENARIO 69
5.10 CASE STUDY ANALYSIS 70
5.10.1 EVONIK INDUSTRIES PROVIDES MEDICAL POLYMERS TO JENACELL GMBH FOR WOUND DRESSINGS, IMPLANTABLE MATERIALS, AND DRUG DELIVERY SYSTEMS 70
5.10.2 ENSINGER OFFERS HIGH-PERFORMANCE, MEDICAL-GRADE POLYMERS FOR HIGH-FREQUENCY SURGERY 70
5.11 IMPACT OF 2025 US TARIFF ON MEDICAL POLYMER MARKET 71
5.11.1 INTRODUCTION 71
5.11.2 KEY TARIFF RATES 72
5.11.3 PRICE IMPACT ANALYSIS 72
5.11.4 IMPACT ON KEY COUNTRIES/REGIONS 73
5.11.4.1 North America 73
5.11.4.2 Europe 73
5.11.4.3 Asia Pacific 73
5.11.5 IMPACT ON END-USE INDUSTRIES 74
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 76
6.1 TECHNOLOGY ANALYSIS 76
6.1.1 KEY TECHNOLOGIES 76
6.1.1.1 Biocompatible and medical-grade polymers 76
6.1.1.2 Medical-grade thermoplastic elastomers 76
6.1.1.3 High-performance medical polymer engineering 77
6.1.2 COMPLEMENTARY TECHNOLOGIES 77
6.1.2.1 Polymer-based additive manufacturing 77
6.1.2.2 Medical polymer surface modification techniques 77
6.1.2.3 Advanced polymer compounding and processing 78
6.2 TECHNOLOGY/PRODUCT ROADMAP 78
6.2.1 SHORT TERM (2025-2027) | MEDICAL-GRADE MATERIAL INNOVATION & PERFORMANCE OPTIMIZATION 78
6.2.2 MID-TERM (2027-2030) | ADVANCED MATERIALS, SMART MANUFACTURING & APPLICATION INTEGRATION 79
6.2.3 LONG TERM (2030-2035+) | SUSTAINABLE HIGH-PERFORMANCE POLYMERS & INTELLIGENT MANUFACTURING 80
6.3 PATENT ANALYSIS 80
6.3.1 LEGAL STATUS OF PATENTS 81
6.3.2 JURISDICTION ANALYSIS 82
6.4 FUTURE APPLICATIONS 83
6.4.1 HIGH-PERFORMANCE POLYMERS FOR MEDICAL INSTRUMENTS & DEVICES 83
6.4.2 SUSTAINABLE, BIORESORBABLE & BIO-BASED MEDICAL POLYMERS 84
6.4.3 ADDITIVE MANUFACTURING & PATIENT-SPECIFIC MEDICAL POLYMERS 85
6.4.4 ADVANCED POLYMER PROCESSING, SURFACE ENGINEERING & SMART MATERIALS 85
6.5 IMPACT OF AI/GEN AI ON MEDICAL POLYMER MARKET 86
6.5.1 TOP USE CASES AND MARKET POTENTIAL OF MEDICAL POLYMERS 86
6.5.2 BEST PRACTICES IN MEDICAL POLYMER PROCESSING 87
6.5.3 CASE STUDIES OF AI IMPLEMENTATION IN MEDICAL POLYMER MARKET 88
6.5.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 88
6.5.5 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN MEDICAL POLYMER MARKET 89
7 SUSTAINABILITY AND REGULATORY LANDSCAPE 90
7.1 REGIONAL REGULATIONS AND COMPLIANCE 90
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90
7.1.2 INDUSTRY STANDARDS 94
7.2 IMPACT OF REGULATORY POLICIES AND SUSTAINABILITY INITIATIVES 97
7.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 97
8 CUSTOMER LANDSCAPE & BUYING BEHAVIOUR 100
8.1 INTRODUCTION 100
8.2 DECISION-MAKING PROCESS 100
8.3 KEY STAKEHOLDERS & BUYING CRITERIA 102
8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS 102
8.3.2 BUYING CRITERIA 103
8.4 ADOPTION BARRIERS & INTERNAL CHALLENGES 103
8.5 UNMET NEEDS IN VARIOUS END-USE INDUSTRIES 105
8.6 MARKET PROFITABILITY 106
8.6.1 REVENUE POTENTIAL 107
8.6.2 COST DYNAMICS 107
8.6.3 MARGIN OPPORTUNITIES IN KEY END-USE INDUSTRIES 107
9 MEDICAL POLYMER MARKET, BY APPLICATION 109
9.1 INTRODUCTION 110
9.2 MEDICAL DISPOSABLES 114
9.2.1 INCREASING DEMAND FOR CATHETERS AND SYRINGES TO DRIVE MARKET 114
9.2.2 GLOVES 115
9.2.3 SYRINGES 115
9.2.4 MEDICAL BAGS 115
9.2.5 OTHER MEDICAL DISPOSABLES 116
9.3 MEDICAL INSTRUMENTS & DEVICES 116
9.3.1 INCREASING USE OF ADVANCED AND MINIMALLY INVASIVE MEDICAL DEVICES TO DRIVE MARKET 116
9.3.2 MEDICAL TUBES 116
9.3.3 CATHETERS 117
9.3.4 DRUG DELIVERY INSTRUMENTS 117
9.3.5 OTHER MEDICAL INSTRUMENTS & DEVICES 118
9.4 PROSTHETICS 118
9.4.1 RISING DEMAND FOR ADVANCED LIMB PROSTHESES AND IMPLANTS TO DRIVE MARKET 118
9.4.2 IMPLANTS 118
9.4.3 LIMB PROSTHESIS 119
9.4.4 OTHER PROSTHETICS APPLICATIONS 119
9.5 DIAGNOSTIC INSTRUMENTS & TOOLS 119
9.5.1 INCREASING DEMAND IN SURGICAL AND PROCEDURAL APPLICATIONS TO DRIVE MARKET 119
9.5.2 DENTAL TOOLS 120
9.5.3 SURGICAL INSTRUMENTS 120
9.5.4 OTHER DIAGNOSTIC INSTRUMENTS & TOOLS 121
9.6 OTHER APPLICATIONS 121
10 MEDICAL POLYMER MARKET, BY TYPE 122
10.1 INTRODUCTION 123
10.2 MEDICAL PLASTICS 128
10.2.1 ADVANCEMENTS IN MATERIAL SCIENCE AND MANUFACTURING TECHNOLOGIES TO DRIVE MARKET 128
10.2.2 POLYPROPYLENE 128
10.2.3 POLYVINYL CHLORIDE 128
10.2.4 POLYETHYLENE 129
10.2.5 POLYSTYRENE 129
10.2.6 ENGINEERING & HIGH-PERFORMANCE PLASTICS 129
10.2.6.1 Polyether ether ketone 129
10.2.6.2 Nylon/polyamide 130
10.2.6.3 Polyphenylsulfone 130
10.2.6.4 Polysulfones 130
10.2.6.5 Polymethyl methacrylate 131
10.2.6.6 Polycarbonate 131
10.2.6.7 Acrylonitrile butadiene styrene 131
10.2.6.8 Other engineering & high-performance plastics 131
10.2.7 OTHER MEDICAL PLASTICS 132
10.3 MEDICAL ELASTOMERS 132
10.3.1 FLEXIBILITY, DURABILITY, AND BIOCOMPATIBILITY TO DRIVE MARKET 132
10.3.2 SILICONE 132
10.3.3 THERMOPLASTIC ELASTOMERS 133
10.3.3.1 Thermoplastic polyurethane 133
10.3.3.2 Thermoplastic vulcanizates 134
10.3.3.3 Thermoplastic styrenic elastomers 134
10.3.3.3.1 Poly (styrene-butadiene-styrene) 134
10.3.3.3.2 Styrene-ethylene-butylene-styrene 135
10.3.3.4 Thermoplastic copolyester elastomers 135
10.3.4 OTHER MEDICAL ELASTOMERS 135
11 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY 136
11.1 INTRODUCTION 137
11.2 EXTRUSION TUBING 139
11.2.1 INCREASING USE IN INTRAVENOUS DELIVERY SYSTEMS, CATHETERS, AND SURGICAL INSTRUMENTS TO DRIVE MARKET 139
11.3 COMPRESSION MOLDING 139
11.3.1 RISING USE IN PROSTHETIC AND ORTHOPEDIC COMPONENTS TO FUEL DEMAND 139
11.4 INJECTION MOLDING 139
11.4.1 INCREASING USE IN SYRINGES, SURGICAL INSTRUMENTS, AND MEDICAL DEVICE COMPONENTS TO SUPPORT MARKET GROWTH 139
11.5 OTHER MANUFACTURING TECHNOLOGIES 140
12 MEDICAL POLYMER MARKET, BY REGION 141
12.1 INTRODUCTION 142
12.2 NORTH AMERICA 144
12.2.1 US 155
12.2.1.1 Strong medical R&D and device innovation to support demand 155
12.2.2 CANADA 163
12.2.2.1 Expanding medical device manufacturing and healthcare demand to support market 163
12.2.3 MEXICO 171
12.2.3.1 Expansion of medical-device manufacturing to support market growth 171
12.3 ASIA PACIFIC 179
12.3.1 CHINA 191
12.3.1.1 Establishment of medical device manufacturing units and investment in healthcare-related sectors to drive market 191
12.3.2 INDIA 199
12.3.2.1 Expansion of domestic medical device manufacturing to drive demand 199
12.3.3 SOUTH KOREA 207
12.3.3.1 Advanced medical device manufacturing and technology development to drive market 207
12.3.4 JAPAN 215
12.3.4.1 Aging population and advanced medical-device technologies to support market growth 215
12.3.5 AUSTRALIA 223
12.3.5.1 Strong medical device manufacturing and regulatory standards to support market growth 223
12.3.6 REST OF ASIA PACIFIC 231
12.4 EUROPE 239
12.4.1 GERMANY 250
12.4.1.1 Advanced medical device manufacturing and aging population to support market growth 250
12.4.2 FRANCE 258
12.4.2.1 Aging population and advanced medical-device manufacturing to support market growth 258
12.4.3 UK 266
12.4.3.1 Growing medical device industry and government support for innovation to drive market 266
12.4.4 ITALY 274
12.4.4.1 Strong production facilities with presence of global players to propel market growth 274
12.4.5 SPAIN 282
12.4.5.1 Growing medical technology industry and government support to drive market 282
12.4.6 REST OF EUROPE 290
12.5 SOUTH AMERICA 298
12.5.1 BRAZIL 309
12.5.1.1 Aging population and expanding medical device industry to drive market 309
12.5.2 ARGENTINA 317
12.5.2.1 High import dependence and evolving medical device regulations to support market 317
12.5.3 REST OF SOUTH AMERICA 325
12.6 MIDDLE EAST & AFRICA 333
12.6.1 GCC COUNTRIES 345
12.6.1.1 Saudi Arabia 345
12.6.1.1.1 Healthcare transformation and medical device localization to support market growth 345
12.6.1.2 UAE 353
12.6.1.2.1 Modernization of healthcare industry to drive market 353
12.6.1.3 Rest of GCC 361
12.6.2 SOUTH AFRICA 369
12.6.2.1 Localization of medical device production to support market 369
12.6.3 REST OF MIDDLE EAST & AFRICA 377
13 COMPETITIVE LANDSCAPE 386
13.1 OVERVIEW 386
13.2 KEY PLAYERS' STRATEGIES 386
13.3 REVENUE ANALYSIS, 2022–2025 389
13.4 MARKET SHARE ANALYSIS, 2025 389
13.5 COMPANY VALUATION AND FINANCIAL METRICS 393
13.6 BRAND/PRODUCT COMPARISON ANALYSIS 394
13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 395
13.7.1 STARS 395
13.7.2 EMERGING LEADERS 395
13.7.3 PERVASIVE PLAYERS 395
13.7.4 PARTICIPANTS 395
13.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 397
13.7.5.1 Company footprint 397
13.7.5.2 Region footprint 397
13.7.5.3 Type footprint 398
13.7.5.4 Manufacturing technology footprint 399
13.7.5.5 Application footprint 400
13.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 401
13.8.1 PROGRESSIVE COMPANIES 401
13.8.2 RESPONSIVE COMPANIES 401
13.8.3 DYNAMIC COMPANIES 402
13.8.4 STARTING BLOCKS 402
13.8.5 COMPETITIVE BENCHMARKING: KEY STARTUPS/SMES, 2025 403
13.8.5.1 Detailed list of key startups/SMEs 403
13.8.5.2 Competitive benchmarking of key startups/SMEs 404
13.9 COMPETITIVE SCENARIO 406
13.9.1 PRODUCT LAUNCHES 406
13.9.2 DEALS 408
13.9.3 EXPANSIONS 410
14 COMPANY PROFILES 414
14.1 MAJOR PLAYERS 414
14.1.1 BASF SE 414
14.1.1.1 Business overview 414
14.1.1.2 Products/Services/Solutions offered 415
14.1.1.3 Recent developments 417
14.1.1.3.1 Product launches 417
14.1.1.3.2 Expansions 417
14.1.1.4 MnM view 418
14.1.1.4.1 Key strengths 418
14.1.1.4.2 Strategic choices 418
14.1.1.4.3 Weaknesses and competitive threats 418
14.1.2 SABIC 420
14.1.2.1 Business overview 420
14.1.2.2 Products/Services/Solutions offered 421
14.1.2.3 Recent developments 423
14.1.2.3.1 Product launches 423
14.1.2.3.2 Deals 423
14.1.2.4 MnM view 424
14.1.2.4.1 Key strengths 424
14.1.2.4.2 Strategic choices 424
14.1.2.4.3 Weaknesses and competitive threats 425
14.1.3 COVESTRO AG 426
14.1.3.1 Business overview 426
14.1.3.2 Products/Services/Solutions offered 427
14.1.3.3 Recent developments 429
14.1.3.3.1 Product launches 429
14.1.3.3.2 Expansions 429
14.1.3.4 MnM view 430
14.1.3.4.1 Key strengths 430
14.1.3.4.2 Strategic choices 431
14.1.3.4.3 Weaknesses and competitive threats 431
14.1.4 CELANESE CORPORATION 432
14.1.4.1 Business overview 432
14.1.4.2 Products/Services/Solutions offered 433
14.1.4.3 Recent developments 434
14.1.4.3.1 Deals 434
14.1.4.3.2 Expansions 435
14.1.4.4 MnM view 435
14.1.4.4.1 Key strengths 435
14.1.4.4.2 Strategic choices 435
14.1.4.4.3 Weaknesses and competitive threats 436
14.1.5 EVONIK INDUSTRIES 437
14.1.5.1 Business overview 437
14.1.5.2 Products/Services/Solutions offered 438
14.1.5.3 Recent developments 439
14.1.5.3.1 Product launches 439
14.1.5.3.2 Deals 440
14.1.5.3.3 Expansions 441
14.1.5.4 MnM view 441
14.1.5.4.1 Key strengths 441
14.1.5.4.2 Strategic choices 442
14.1.5.4.3 Weaknesses and competitive threats 442
14.1.6 ARKEMA 443
14.1.6.1 Business overview 443
14.1.6.2 Products/Services/Solutions offered 444
14.1.6.3 Recent developments 446
14.1.6.3.1 Deals 446
14.1.6.3.2 Expansions 446
14.1.6.4 MnM view 447
14.1.7 SOLVAY 448
14.1.7.1 Business overview 448
14.1.7.2 Products/Services/Solutions offered 449
14.1.7.3 Recent developments 451
14.1.7.3.1 Product launches 451
14.1.7.4 MnM view 451
14.1.8 KURARAY CO., LTD. 452
14.1.8.1 Business overview 452
14.1.8.2 Products/Services/Solutions offered 453
14.1.8.3 Recent developments 454
14.1.8.3.1 Expansions 454
14.1.8.4 MnM view 455
14.1.9 MOMENTIVE PERFORMANCE MATERIALS INC. 456
14.1.9.1 Business overview 456
14.1.9.2 Products/Services/Solutions offered 456
14.1.9.3 Recent developments 458
14.1.9.3.1 Product launches 458
14.1.9.3.2 Expansions 459
14.1.9.4 MnM view 459
14.1.10 DUPONT 460
14.1.10.1 Business overview 460
14.1.10.2 Products/Services/Solutions offered 461
14.1.10.3 Recent developments 462
14.1.10.3.1 Product launches 462
14.1.10.3.2 Deals 463
14.1.10.3.3 Expansions 464
14.1.10.4 MnM view 464
14.2 OTHER PLAYERS 465
14.2.1 TRINSEO 465
14.2.2 KRATON CORPORATION 466
14.2.3 TOTAL PLASTICS 467
14.2.4 SIMONA AMERICA 468
14.2.5 DSM 469
14.2.6 INVIBIO 470
14.2.7 AVIENT CORPORATION 470
14.2.8 RTP COMPANY 471
14.2.9 TEKNI-PLEX, INC. 472
14.2.10 TEKNOR APEX 473
14.2.11 MITSUBISHI CHEMICAL ADVANCED MATERIALS 474
14.2.12 WACKER CHEMIE 474
14.2.13 HARDIE POLYMERS 475
14.2.14 ELIX POLYMERS 476
14.2.15 INNOVATIVE POLYMER COMPOUNDS LTD. 477
15 RESEARCH METHODOLOGY 478
15.1 RESEARCH DATA 478
15.1.1 SECONDARY DATA 480
15.1.1.1 List of major secondary sources 480
15.1.1.2 Key data from secondary sources 480
15.1.2 PRIMARY DATA 481
15.1.2.1 Key data from primary sources 481
15.1.2.2 List of primary interview participants—demand and supply side 482
15.1.2.3 Key industry insights 482
15.1.2.4 Breakdown of primary interviews 482
15.2 MARKET SIZE ESTIMATION 483
15.2.1 BOTTOM-UP APPROACH 483
15.2.2 TOP-DOWN APPROACH 484
15.3 BASE NUMBER CALCULATION 484
15.3.1 DEMAND-SIDE APPROACH 484
15.3.2 SUPPLY-SIDE APPROACH 485
15.4 MARKET FORECAST APPROACH 485
15.4.1 SUPPLY SIDE 485
15.4.2 DEMAND SIDE 485
15.5 DATA TRIANGULATION 485
15.6 FACTOR ANALYSIS 486
15.7 ASSUMPTIONS 487
15.8 LIMITATIONS AND RISKS 487
16 APPENDIX 488
16.1 DISCUSSION GUIDE 488
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 491
16.3 CUSTOMIZATION OPTIONS 493
16.4 RELATED REPORTS 493
16.5 AUTHOR DETAILS 494